Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07200193
Recruiting
A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
Phase 1/2 · France, United Kingdom, Hong Kong, New Zealand · 4 sites
Registry update: 15 Jun 2026
Conflicting statuses (not updated in the registry for 4 months)
NCT07174336
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Greece, Ireland, Italy, Japan, South Korea, Singapore, Taiwan, United States · 362 sites
Registry update: 4 Nov 2026
NCT05962541
Recruiting
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
Phase 4 · Italy · 1 site
Registry update: 31 Dec 2025
NCT07124611
Recruiting
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
Not applicable · United States · 1 site
Registry update: 19 Feb 2026
NCT07586813
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
Phase 2 · China · 1 site
Registry update: 14 May 2026
NCT07455994
Recruiting
Dysautonomia in Children With Type 1 Diabetes
Not applicable · France · 1 site
Registry update: 6 Mar 2026
NCT07234695
Recruiting
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Phase 3 · Spain · 5 sites
Registry update: 12 Jan 2026
NCT07148050
Recruiting
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Phase 1 · United States · 1 site
Registry update: 17 Feb 2026
NCT07225712
Recruiting
A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
Phase 3 · Japan · 1 site
Registry update: 14 Jan 2026
NCT07570212
Recruiting
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Not applicable · China · 1 site
Registry update: 29 Jun 2026
2025-522528-29-00
Recruiting
The effect of colchicine, on insulin sensitivity in individuals with type 1 diabetes and systemic low-grade inflammation (INS1GHT)
Phase 2 · Denmark · 1 site
Registry update: 26 Sept 2025
NCT07243782
Recruiting
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Not applicable · South Korea · 1 site
Registry update: 5 Mar 2026
NCT07301060
Recruiting
Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control
Not applicable · United States · 2 sites
Registry update: 24 Dec 2025
NCT07336147
Recruiting
Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma
Phase 2 · Taiwan · 1 site
Registry update: 17 Aug 2026
NCT07251998
Recruiting
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Phase 2 · China · 1 site
Registry update: 31 Dec 2025
NCT07265947
Recruiting
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Phase 2 · Bulgaria, Spain, France, Israel, United States · 42 sites
Registry update: 2 Nov 2026
NCT07602192
Recruiting
Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response
Not applicable · South Korea · 2 sites
Registry update: 7 Jul 2026
NCT07404761
Recruiting
Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments
Not applicable · Israel · 1 site
Registry update: 11 Feb 2026
NCT07286578
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Not applicable · Belgium, Spain, United Kingdom, United States · 15 sites
Registry update: 30 Oct 2026
NCT07586826
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Phase 2 · China · 1 site
Registry update: 14 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.